Presence of mucosal change in the urinary bladder in nonhematuric patients with long-term exposure and/or accumulating high-dose cyclophosphamide

Urologia Internationalis

Volumn 61, Issue 1, 1998, Pages 8-11

  Kimura, Motohiko ^a,b   Tomita, Yoshihiko ^b   Morishita, Hideo ^a   Takahashi, Kota ^b  

^a NAGAOKA RED CROSS HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Cyclophosphamide; Cystitis, presymptomatic; Prophylactic cystoscopy

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BLADDER MUCOSA; CLINICAL ARTICLE; CYSTOSCOPY; DRUG MEGADOSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEMORRHAGIC CYSTITIS; HUMAN; HYPEREMIA; LONG TERM EXPOSURE; MALE; PRIORITY JOURNAL; TELANGIECTASIA; URINALYSIS;

ADULT; AGED; CYCLOPHOSPHAMIDE; CYSTITIS; CYSTOSCOPY; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; URINARY BLADDER;

EID: 0031736753     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030275     Document Type: Article

References (14)

1. Coggins PR, Ravdin RG, Eisman SH: Clinical pharmacology and preliminary evaluation of cytoxan (cyclophosphamide). Cancer Chemother Rep 1959;3:9-11.
2. Cox PJ: Cyclophosphamide cystitis. Identification of acrolein as the causative agent. Biochem Pharmacol 1979;28:2045-2049.
3. Forni AM, Koss LG, Geller W: Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man. Cancer 1964;17:1348-1355
4. Johnson WW, Meadows DC: Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. N Engl J Med 1971;284:290-294.
5. deVries CR, Freiha FS: Hemorrhagic cystitis. A review. J Urol 1990;143:1-9.
6. DeFronza RA, Braine H, Colvin OM, Davis PJ: Water intoxication in man after cyclophosphamide therapy: Time course and relation to drug activation. Ann Intern Med 1973;78:861-869.
7. Bryant BM, Jarman M, Ford HT, Smith IE: Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma. Lancet 1980;ii:657-659.
8. Stillwell TJ, Benson RC: Cyclophosphamide-induced hemorrhagic cystitis: A review of 100 patients. Cancer 1988;61:651-657.
9. Mukamel E, Lupu A, deKernion JB: Alum irrigation for severe bladder hemorrhage. J Urol 1986;135:784-785.
10. Levine LA, Jarrard DF: Treatment of cyclophosphamide-induced hemorrhagic cystitits with intravesical carboprost tromethamine. J Urol 1993;149:719-723
11. Liu YK, Harty JI, Steinbock GS, Holt HA, Golrestein DH, Amin M: Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol 1990;144:41-43.
12. Pyeritz RE, Droller MJ, Bender WL, Saral R: An approach to the control of massive hemorrhage in cyclophosphamide-induced cystitis by intravenous vasopressin. A case report. J Urol 1978;120:253-254.
13. Shameem IA, Shimabukura T, Shirataki S, Yamamoto N, Maekawa N, Naito K: Hyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitis. Eur Urol 1992;22:263-264
14. Okaneya T, Kontani K, Komiyama I, Takezaki T: Severe cyclophosphamide-induced hemorrhagic cystitis successfully treated by total cystectomy with ileal neobladder substitution. A case report. J Urol 1993;150:1909-1940.